While many orthosteric ligands have been developed for the mGlu 2 receptor, little is known about their target binding kinetics and how these relate to those of the endogenous agonist glutamate. Here, the kinetic rate constants, i.e. k on and k off , of glutamate were determined for the first time followed by those of the synthetic agonist LY354740 and antagonist LY341495. To increase the understanding of the binding mechanism and impact of allosteric modulation thereon, kinetic experiments were repeated in the presence of allosteric modulators. Functional assays were performed to further study the interplay between the orthosteric and allosteric binding sites, including an impedance-based morphology assay.
Introduction
Glutamate is the most important excitatory neurotransmitter in the central nervous system where it modulates synaptic responses via activation of ionotropic glutamate receptors and metabotropic glutamate (mGlu) receptors [1] . mGlu receptors are class C G protein-coupled receptors (GPCRs) that structurally consist of a large extracellular glutamate binding domain, the so-called Venus Flytrap (VFT) domain, which is connected via a cysteine-rich domain to the typical seventransmembrane (7TM) domain [2] . The mGlu 2 receptor, which is expressed presynaptically in the periphery of the synapse, is of interest in drug discovery as it negatively modulates the release of glutamate into the synapse [3] . Hence, mGlu 2 receptor activation can reduce glutamate hyperfunction in diseases like schizophrenia and anxiety [4, 5] , whereas mGlu 2 receptor blockade can be beneficial for glutamate hypofunction in depression and impaired cognition [6, 7] .
A variety of glutamate-like ligands targeting the orthosteric binding site in the VFT domain was developed including the reference agonist LY354740 and antagonist LY341495 [8, 9] . Until the recent disclosure of the mGlu 2 selective agonist LY2812223 [10] , development of orthosteric ligands presented challenges for receptor subtype selectivity and therefore discovery efforts shifted to allosteric modulators that bind in a less conserved pocket in the 7TM domain [11] . Allosteric modulators enhance or inhibit the potency and/or efficacy of the endogenous/orthosteric agonist with little or no intrinsic activity [12] . Two positive allosteric modulators (PAMs) have advanced into clinical trials: AZD8529 [13, 14] and JNJ-40411813/ADX71149 [15, 16] . Reference PAMs in the field include BINA [17] , JNJ-40068782 [18] and https://doi.org/10.1016/j.bcp.2018.07.014 Received 9 May 2018; Accepted 14 July 2018 JNJ-46281222 [19] . A number of negative allosteric modulators (NAMs) have been characterized in vivo, including a recent series of Janssen, RO4491533 and decoglurant of which the latter has advanced into clinical trials [7, [20] [21] [22] .
Over the last decade it has become increasingly clear that in vivo efficacy is not only depending on optimized in vitro affinity and efficacy parameters, but also on optimized kinetics of both receptor binding and activation [23] . The dissociation rate constant k off and its derived parameter residence time (RT = 1/k off ) have received increasing attention since the in vivo efficacy of multiple marketed GPCR drugs was shown to be related to long RT at the target, such as the long-acting M 3 receptor antagonist tiotropium [24, 25] . Although most kinetic studies have emphasized dissociation rate constants, association rate constants have also been described to be important for fast onset of drug action, a high receptor occupancy and even a longer duration of action [26, 27] . The importance of k on was further underscored for its potential in drug safety by Sykes et al. (2017) who showed that extrapyramidal side effects induced by dopamine D 2 receptor antagonists are linked to k on rather than k off as had been the general hypothesis so far [28] .
We have recently shown the importance of k on and k off for mGlu 2 PAMs, where their affinity was k on -driven and their k off was linked to in vivo efficacy [29] . Except for this study, no previous studies have extensively focused on binding kinetics of mGlu 2 ligands. Understanding of binding kinetics may also be helpful in drug discovery of novel orthosteric mGlu 2 ligands. Moreover, appreciating the kinetic binding parameters of the endogenous agonist is important when designing orthosteric ligands as they have to compete for the same binding site [30] . Furthermore, determination of alterations of the kinetic parameters of the endogenous ligand induced by an allosteric modulator will provide valuable mechanistic insights. Since kinetic binding parameters of the endogenous mGlu 2 agonist glutamate have not been quantified before we set up a kinetic radioligand binding assay to enable quantification of kinetic parameters for orthosteric ligands. The major mechanism of action of many allosteric modulators is to modulate endogenous agonist affinity by affecting its kinetic binding parameters, as affinity is determined by K D = k off /k on . Therefore, kinetic binding experiments with orthosteric ligands were also performed in the presence of a PAM or NAM. Additionally, we performed functional assays, i.e. [ 35 S]GTPγS binding assays measuring G protein activation and a label-free biosensor assay that measures changes in cell morphology representing a more integral cellular response. These functional assays were used to further study the interplay between the orthosteric and allosteric binding sites, and its effect on the level of functional efficacy. Importantly, the cell morphology assay enabled recording in real-time, thereby providing the opportunity to evaluate functional receptor-induced responses over time in addition to the timedependent binding kinetics assays. This work provides insights on the binding kinetics of orthosteric ligands at the mGlu 2 receptor and modulation thereof by PAMs or NAMs. As such, it contributes to increased molecular understanding which may strengthen future drug discovery projects focusing on the development of both orthosteric ligands or allosteric modulators for the mGlu 2 receptor as well as for other GPCRs. proline and 400 µg·mL −1 G418 at 37°C and 5% CO 2 . Cells were subcultured twice every week at a ratio of 1:10.
Materials and methods

Chemicals and reagents
LY354740
Membrane preparation
Membrane preparation was performed as previously described [19] . Incubations were performed at 0°C. Nonspecific binding was determined using 1 mM glutamate and DMSO concentrations were ≤0.25%. Displacement experiments were carried out using radioligand and a competing ligand at multiple concentrations. Samples were incubated for 60 min, after which receptor-bound radioactivity was determined.
Association experiments were performed by incubation of radioligand in the absence or presence of allosteric modulator at 1 µM with membrane aliquots. The amount of receptor-bound radioligand was determined at different time points up to 60 min.
Dissociation experiments were carried out by a 60 min pre-incubation of radioligand and membrane aliquots in the absence or presence of allosteric modulator at 1 µM. The amount of receptor-bound radioligand was determined after dissociation at different time points up to 60 min which was initiated by addition of 5 µl assay buffer containing LY341495 (final concentration 10 µM).
Competition association experiments were performed by incubation of radioligand, competing ligand at its IC 50 concentration in the absence or presence of allosteric modulator at 1 µM with membrane aliquots. The amount of receptor-bound radioligand was determined at different time points up to 60 min.
For all assays, incubations were terminated by rapid filtration over GF/C filter plates (PerkinElmer) using a PerkinElmer 96w Filtermate harvester. Subsequently filters were washed five times using ice-cold wash buffer (50 mM Tris-HCl pH 7.4). Filter-bound reactivity was determined using liquid scintillation spectrometry on a Microbeta 2450 2 microplate counter (PerkinElmer). 
Impedance-based morphology assays
Impedance-based morphology assays were performed using the realtime cell analyser (RTCA) xCELLigence SP system (ACEA Biosciences, San Diego, CA, USA) [31, 32] , as previously described [33] . The system measures electrical impedance generated by adherence of cells to goldcoated electrodes at the bottom of 96 wells PET E-plates (obtained from Bioké, Leiden, the Netherlands). Changes in impedance (Z) are measured continuously and are displayed as Cell Index (CI), which is defined as (Z i − Z 0 ) Ω/15 Ω. Z i is the impedance at a given time and Z 0 is the baseline impedance measured at the start of the experiment in the absence of cells. Baseline impedance was determined using 45 µl culture medium (as described under 'cell culture') per well in a 96 well Eplate. 40,000 CHO-K1_hmGlu 2 cells were added in a volume of 50 µl per well. After resting at room temperature for 30 min, the plate was mounted in the recording station within a humidified 37°C, 5% CO 2 incubator. Impedance was measured every 15 min overnight. 18 h after cell seeding, wells were stimulated with increasing concentrations of glutamate in the absence or presence of 1 µM PAM JNJ-46281222, resulting in final well volumes of 100 µl. DMSO concentrations were 0.025% and constant between wells.
Data analysis
Data analyses were performed using Prism 7.00 (GraphPad software, San Diego, CA, USA). pIC 50 values in radioligand displacement assays were obtained by non-linear regression curve fitting into a sigmoidal concentration-response curve using the equation: Y = Bottom + (Top-Bottom)/(1 + 10^(X-LogIC 50 )). pK i values were obtained from pIC 50 values using the Cheng-Prusoff equation [34] . Dissociation rate constant k off was obtained using an exponential decay analysis of radioligand binding. Association rate constant k on was determined using the equation
, in which L is the concentration of radioligand and k obs was determined using an exponential association analysis of radioligand binding.
Association and dissociation rate constants for unlabelled mGlu 2 PAMs were determined by nonlinear regression analysis of competition association data as described by Motulsky and Mahan [35] . 50 values from the impedance-based morphology assay. Baseline-corrected ΔCI levels at indicated time points were used to obtain these concentration-response curves. Data are shown as mean ± SEM of at least three individual experiments performed in duplicate. Statistical analyses were performed as indicated. If p-values were below 0.05, observed differences were considered statistically significant.
Results
Affinity of orthosteric ligands in the absence or presence of allosteric modulators
The affinities of orthosteric agonists glutamate and LY354740 and antagonist LY341495 were determined by [ Table 1 ). The affinity of both the endogenous agonist glutamate and the synthetic agonist LY354740 was significantly increased in the presence of all PAMs. Specifically, in presence of JNJ-46281222, glutamate affinity was increased by 7-fold (pK i 4.52 ± 0.04 to 5.40 ± 0.08 in the absence and presence of JNJ-46281222, respectively), while the affinity of LY354740 was increased by 5-fold (pK i Fig. 1D ), which indicates that they bind to an allosteric site at the mGlu 2 receptor.
Binding kinetics of orthosteric ligands
We set-up radioligand binding assays allowing the determination of binding kinetics of orthosteric ligands in the absence or presence of allosteric modulators. The kinetic binding parameters k on and k off of [ 3 H]LY341495 were determined using classical (direct) association and dissociation assays ( Fig. 2A, Table 2 ). [ . Based on these k obs and k off values and the concentration of the radioligand used, k on was calculated as 2.2 ± 0.17 × 10 6 M −1 s −1 . To obtain kinetic binding parameters for unlabelled orthosteric ligands, a competition association assay was performed ( Fig. 2B-D) . The assay was first validated using unlabelled LY341495, for which k on and k off values were comparable to those obtained in the classical association and dissociation assays (Table 3) . Subsequently, the kinetic binding parameters of glutamate and LY354740 were assessed ( Fig. 2C,D Tables 1 and 3 ).
The effect of allosteric modulators on the binding kinetics of orthosteric ligands
The kinetic binding parameters k on and k off of glutamate, LY354740 and LY341495 were determined in the presence of PAM JNJ-46281222 or NAM RO4491533 at 1 µM ( Fig. 2B-D ; Tables 2 and 3 Values represent the mean ± SEM of three individual experiments performed in duplicate. Statistical analyses were performed using a one-way ANOVA with Dunnett's post-test. * < 0.05, *** < 0.001. Tables 2 and 3 . Data represent the mean ± SEM of at least three individual experiments performed in duplicate. Together, this resulted in an approximately 5-fold increased 'kinetic' affinity (K D ) for glutamate from 23 ± 6.9 to 4.7 ± 0.6 µM, which was also observed in the equilibrium displacement assays (K i values, compare Tables 1 and 3 ). In the presence of 1 µM RO4491533, the k on value of glutamate was significantly increased by 3-fold to 5.2 ± 0.37 × 10
, while the k off value was also significantly increased by 3-fold to 0.12 ± 0.009 s
. As a result, the kinetic K D value did not change compared to glutamate in the absence of NAM (24 ± 2.4 µM and 23 ± 6.9 µM in absence or presence of NAM, respectively).
The k on value of LY354740 was left unchanged in the presence of 1 µM JNJ-46281222 (7. Fig. 2A, Table 2 ), as well as for the completion association assays (Fig. 2D, Table 3 ). Hence, K D values were similar to those obtained in the absence of allosteric modulator. (Fig. 3A) . Secondly, the effects of increasing concentrations of JNJ-46281222 or RO4491533 on the concentration-response curves of LY354740 were assessed (Fig. 3B, Table 4 ). Increasing concentrations of the PAM JNJ-46281222 induced a concentration-dependent increase in E max up to approximately 220% at a concentration of 30 nM or higher. Moreover, the potency of LY354740 was increased significantly from 6.94 ± 0.04 in the absence of PAM to 7.69 ± 0.07 in the presence of 100 nM JNJ-46281222. In contrast, when LY35470 was treated with performed using a one-way ANOVA with Dunnett's post-test. * < 0.05, ** < 0.01, *** < 0.001. Table 4 ). Interestingly, the potency of LY354740 did not change significantly in the presence of increasing NAM concentrations.
Effect of PAM JNJ-46281222 on duration of glutamate-induced cellular response using an impedance-based morphology assay
To gain further insights in the functional impact of allosteric modulation, receptor activation by glutamate was evaluated using an impedance-based morphology assay (i.e. xCELLigence). This method can record receptor-specific cellular responses in real-time, and thus compound-induced changes in cellular dynamics can be measured over time. Glutamate-induced responses were recorded at increasing concentrations in the absence and presence of 1 µM PAM JNJ-46281222 resulting in a concentration-dependent increase in impedance, depicted as Cell Index (Fig. 4A,B) (Table 4) . Interestingly, the duration of the glutamate-induced response in the presence of PAM was also increased from approximately 45 to over 60 min. To further evaluate this effect, concentration-response curves of glutamate in the absence and presence of the PAM were obtained at two different time points after stimulation, i.e. 15 and 45 min (Fig. 4C,D) . Comparison of these concentration-response curves yielded a 2-fold decrease in efficacy for the curve from the later time point (Fig. 4C) , congruent with the almost loss of glutamate signal in the absence of PAM at 45 min (Fig. 4A) . In contrast, the glutamate efficacy in the presence of PAM did not change significantly, when comparing the concentration-response curves of 15 and 45 min after stimulation. This is in line with the observation that the duration of the glutamate-induced response is prolonged by the PAM to approximately 60 min, and thus a decrease in cellular impedance was not yet observed at 45 min (Fig. 4B) . Of note, when comparing the potencies for each condition, i.e. glutamate in the absence or presence of PAM, these were not significantly different at the two time points selected (Fig. 4C,D) .
Correlations and kinetic map
To compare the parameters obtained from the different radioligand binding assays, correlation plots were made (Fig. 5A-C (Fig. 5A, R2 = 0.95) , further corroborating the robustness of the latter assay. A significant correlation was also found between affinity (K i ) and association rate constants (k on ) (Fig. 5B,  R2 = 0.99) . Such a correlation, however, was not found between affinity (K i ) and dissociation rate constants (k off ) (Fig. 5C, R2 = 0.29) , indicating that affinities of these orthosteric ligands are predominantly k on -driven.
A kinetic map was made, to further compare the kinetic and affinity parameters (Fig. 5D) . In this map k on (x-axis), k off (y-axis) and K D (diagonal lines) values were plotted. k on and K D values ranged over more than three orders of magnitude, whereas k off values were only spread within a single order of magnitude and therefore appeared at a similar horizontal level in the kinetic map (Fig. 5D) .
As shown in Table 3 , k on and k off values of glutamate were affected by both PAM and NAM, which was exemplified in the kinetic map by a spread in symbols. Specifically, in the presence of PAM, the k off of glutamate was decreased by 3-fold. In the presence of NAM both k on and k off were increased 3-fold resulting in the same affinity as illustrated by a diagonal shift of the NAM symbol, i.e. a shift along the line of similar K D . In the presence of PAM, the k off of LY354740 was similarly affected compared to glutamate, i.e. in both cases this resulted in a downward shift on the kinetic map, whereas in the presence of NAM no significant shifts were observed, resulting in nearly overlapping symbols. Since the k on and k off values of LY34195 were not affected by PAM or NAM all three symbols are overlapping in the kinetic map.
To compare the functional potency of agonists in the absence or presence of PAM to the kinetic parameters k on and k off further correlation plots were made (Fig. 5E-G) . Firstly, the potencies (EC 50 ) obtained in [ 35 S]GTPγS assays of agonists glutamate and LY354740 were shown to be strongly correlated (Fig. 5E , R2 = 0.99) to the affinity obtained from competition association assays (K D ), showing that potencies are driven by the agonist binding affinities although the absolute values differed by approximately one log unit. As the affinities were shown to be correlated to on-rates, a correlation was also found between agonist potencies and k on values (Fig. 5F , R2 = 0.84), showing that a high agonist potency is obtained from a high on-rate. No correlation was found between agonist potency and dissociation rate constant (k off ) (Fig. 5G , R2 = 0.28). However, in the presence of PAM the agonist k off was decreased for both glutamate and LY354740, which then was the driver for an increased agonist potency, as was also observed for agonist affinity in the presence of PAM.
Discussion
Traditionally, affinity and potency are the main parameters studied in in vitro drug discovery. In addition, a ligand's target binding kinetic parameters are nowadays commonly appreciated as valuable information for the early phases of drug discovery [25] . For the development of novel and effective orthosteric mGlu 2 ligands it is valuable to know their kinetic binding parameters, but also to understand how these relate to the binding kinetics of the endogenous agonist glutamate [30] . Moreover, a variety of high affinity and selective PAMs and NAMs have been developed that modulate glutamate potency, efficacy and/or affinity. As for orthosteric ligands, it is equally useful to know the allosteric modulator's binding kinetics [29] . Likewise it is also relevant to know how a modulator affects the kinetic binding parameters of the endogenous ligand glutamate. Hence, in the present study we aimed to increase the understanding of binding kinetics of orthosteric mGlu 2 ligands both on their own and upon modulation by an allosteric ligand.
The orthosteric ligands used in this study were the endogenous agonist glutamate and reference orthosteric ligands LY354740 (agonist) and LY341495 (antagonist). Radioligand displacement experiments EC 50 of glutamate in the presence of 1 µM PAM is from [19] ; potency (EC 50 ) and association rate constant (k on ) (F); potency (EC 50 ) and dissociation rate constant (k off ) (G). (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.) (Fig. 1, Table 1 ) showed that these ligands bind the same orthosteric binding site, which is in line with previous observations [36, 37] . The kinetic parameters k on and k off of glutamate were quantified for the first time, using competition association experiments. To allow the set-up of this assay kinetic [ 3 H]LY341495 binding experiments were performed which showed that this ligand associates to its binding site within four minutes and dissociates in approximately ten minutes ( Fig. 2A) . For the set-up of the competition association assay, the association and dissociation of the radioligand should ideally be slower allowing more data points on the steep part of the curves [38] . This is often achieved by a temperature reduction. However, in these assays the temperature could not be lowered, since it had to be set at 0°C already to allow quantification of kinetic measurements using this commercially available radioligand. Still we could produce robust data between the different binding assays indicating their validity. To obtain values for k on and k off of unlabelled ligands in the absence and presence of allosteric modulators, the Motulsky and Mahan model was used [35, 38] , Table 3 ) is fast in comparison to the series of mGlu 2 PAMs we studied before, which dissociate on a minute-range at 28°C (k off values between 0.00033 and 0.0040 s ), which would be even slower at 0°C [29] . The observation of fast glutamate binding kinetics is in line with studies using FRET sensors that found mGlu 1 receptor conformational changes upon glutamate binding within seconds [39, 40] . Fast receptor dissociation of glutamate relates to its physiological role as a neurotransmitter, where short bursts of glutamate at high concentrations are released into the synapse where it should evoke its function during that burst only [3] . Similarly, fast off-rates were obtained for other endogenous neurotransmitters as exemplified by 2-AG and anandamide on the CB 2 receptor (k off = 0.053 s −1 and 0.012 s −1 at 25°C, respectively) [41] and acetylcholine on the M 3 receptor (k off = 0.093 s −1 at 37°C) [42] .
Comparison of these values is troublesome, since for practical reasons experiments were performed at different temperatures. Still, they all share off-rates on the second to minute scale, indicating fast receptor dissociation particularly when comparing to synthetic ligands at the same receptors [41, 42] . It is generally acknowledged that allosteric modulators may change the affinity and/or potency of agonists by modulating their k on and/or k off values [43] . Generally this has been determined by radioligand dissociation experiments in the presence of allosteric modulators that enable quantification of modulated off-rates [44] . Limitations of such assays are that it is impossible to detect effects on a radioligand's onrate and that the orthosteric/endogenous ligand of interest needs to be radiolabelled. This is not suitable for most endogenous agonists including glutamate due to a too low target affinity, or too high nonspecific binding. Therefore, we used the competition association assay for quantification of both k on and k off values of unlabelled orthosteric ligands in the absence or presence of PAM or NAM, as was recently published for an adenosine A 1 receptor PAM [38] . The presence of PAM JNJ-46281222 at 1 µM significantly reduced the k off of glutamate and LY354740, resulting in an increased affinity for both these agonists. This was in line with the results from the radioligand displacement assay (Table 1) and can be considered a typical PAM effect [43] . A similar effect was also seen in the functional [ 35 S]GTPγS binding assay where the potency of LY354740 was increased by the PAM JNJ-46281222 by almost 6-fold and its efficacy was more than doubled in line with earlier results using glutamate [19] . Furthermore, a decreased k off , i.e. increased residence time, for glutamate in the presence of 1 µM PAM JNJ-46281222 results in a prolonged receptor occupancy, which correlated to a prolonged cellular response in the morphology assay (Fig. 4) . This functional assay is performed on whole cells under physiologically more relevant conditions (i.e. in culture medium, at 37°C, in a CO 2 incubator) and is therefore considered to be more translational than classical functional assays [31, 32] . Furthermore, the assay can be performed in real-time, which enabled translation from kinetic binding parameters towards functional efficacy over time. Previous studies have also used this assay to study the link between receptor binding kinetics, functional activation kinetics and duration of signalling for agonist-induced responses on the dopamine D 2 and neurokinin 1 receptors [45, 46] . Of note, we have previously shown that culture medium contains 100 µM endogenous glutamate [47] , and therefore the enzyme glutamate-pyruvate transaminase (GPT) is often used to reduce this level. In the current study we were interested in the effect of a PAM on glutamate-responses, as this is the endogenous ligand and thus most relevant for PAM drug discovery. Therefore, GPT could not be used as this would deplete exogenous glutamate in addition to endogenous glutamate.
The NAM RO4491533 at 1 µM positively modulated both k on and k off of glutamate (Table 3) , resulting in an unchanged affinity. Of note, these effects on glutamate kinetics cannot be observed in the classical radioligand displacement assays at equilibrium conditions, and would therefore be missed (Table 1) . On the other hand, RO4491533 was not able to change k on and k off of LY354740, which shows that the effects of this NAM on binding kinetics of agonists were probe-dependent [12] . This finding highlights the importance of using endogenous agonists in studies of allosteric modulation, since results on other (synthetic) agonists may provide different conclusions as a result of probe-dependency. The observation that a high 1 µM concentration of NAM RO4491533 did not modulate the affinity of both agonists indicated that these ligands still bind the orthosteric binding site in the presence of this NAM, which is therefore behaving as a silent or neutral allosteric ligand (NAL) concerning orthosteric ligand binding [11] . On the contrary, RO4491533 displayed a strong negative cooperativity in the functional [ 35 S]GTPγS binding assay as it concentration-dependently decreased the efficacy of the agonist LY354740 without changing its potency, eventually resulting in abolished LY354740 efficacy ( Fig. 3 ; Table 4 ), similar to its effects on glutamate activity [22] . This mode of negative allosteric modulation, i.e. only affecting efficacy, has been found across the class C GPCR family. NAMs such as CPCCOEt (mGlu 1 ) and MPEP (mGlu 5 ) also abolished agonist efficacy without modulation of binding affinity [48, 49] . The absence of cooperativity between LY341495 and both PAM and NAM was further illustrated by the observation that k on and k off of LY341495 were not affected by any allosteric modulator (Table 3) . The kinetic parameters of glutamate, LY354740 and LY341495 were most different in k on , ranging over more than three orders of magnitude (from 1.6 ± 0.3 × 10 3 to 2.4 ± 0.18 × 10 6 M −1 min −1 ) as did their affinity values, whereas k off values were all within a 6-fold range (from 0.0087 ± 0.0009 to 0.045 ± 0.010). The correlation plots Fig. 5 show that k on is strongly correlated to the agonist affinity and potency, which indicates that target engagement of orthosteric mGlu 2 ligands is k ondriven. Recent simulation studies have emphasized the role of high k on values for receptor occupancy and drug dosing [26, 27] . A mechanism responsible for these effects may be receptor rebinding, which is described as the binding of newly dissociated ligand from the local environment of the receptor [50] . The interstitial localization of the mGlu 2 receptor may result in more rebinding due to less diffusion and therefore higher local concentrations. However, rebinding to the mGlu 2 receptor seems less likely for glutamate due to its low k on value (both in the absence and presence of a PAM - Table 3 ) and the active lowering of local glutamate concentrations by glutamate transporters expressed on the neuronal cell membrane and surrounding glial cells [51] . In contrast, rebinding may play a more prominent role in binding of synthetic ligands which have higher k on values and are not actively transported away from their site of action, resulting in higher in vivo receptor occupancy [50] . The plots in Fig. 5 furthermore showed that whereas between different PAMs a higher affinity is obtained from a higher k on , the higher agonist affinity and potency obtained in the presence of a PAM results from a lowered k off value as has been shown to be a common mechanism of action for many PAMs at different GPCRs [43] . As shown in Fig. 5 , k off is not correlated to both affinity and potency. This is similar to our recent work on mGlu 2 PAMs and this may therefore be a receptor-specific property [29] . Furthermore, this earlier study provided a first indication that PAM k off values may be correlated to in vivo efficacy, as measured by effects on sleep-wake architecture in rats, more specifically suppression of Rapid Eye Movement (REM) sleep [52] . In the light of the current observation that the presence of a PAM prolonged glutamate-induced cellular responses by decreasing its k off , it may be speculated that k off values of both the PAM and the endogenous agonist are important for the duration of action and thus also for in vivo efficacy. As such, this information is valuable for the design of novel orthosteric and allosteric ligands in early drug discovery.
In conclusion, the set-up of a competition association radioligand binding assay enabled quantification of the parameters of binding kinetics for glutamate for the first time. k off values of the orthosteric ligands were within a single order of magnitude, whereas k on values were spread over more than three orders of magnitude and were strongly correlated to affinity, indicating that mGlu 2 target engagement is driven by k on rather than k off . Binding kinetics of agonists were modulated by the PAM, showing a decrease in k off of both agonists and a prolonged functional response for glutamate. The NAM altered k on and k off of glutamate without changing glutamate's affinity, but did not induce such alterations for agonist LY354740, which indicates probe-dependency. These results show that affinity or potency-only optimization of orthosteric ligands will result in a high k on value but not necessarily optimized k off values, which is essential for optimal in vivo efficacy, as shown by previous studies. Together, this work contributes to an increased understanding of the molecular processes that underlie the mechanism of GPCR allosteric modulation, specifically how allosteric modulators affect the kinetic parameters of the endogenous agonist. Therefore, this study further emphasizes the need for evaluation of binding kinetics during drug discovery of both orthosteric and allosteric drug candidates for the mGlu 2 receptor as well as for other GPCRs.
